Eicosapentaenoyl 1-propanol-2-amide – 5 mg

Brand:
Cayman
CAS:
1638355-66-4
Storage:
-20
UN-No:
De Minimis - 1170 / 3

Monoacylglycerols (MAGs) of ω-3 polyunsaturated fatty acids have diverse physiological and health effects.{27369,29150,29151} In particular, MAGs containing docosahexaenoic acid (Item No. 90310) or eicosapentaenoic acid (EPA; Item No. 90110) have anti-proliferative properties against colon and lung cancer cell lines.{28443} Eicosapentaenoyl 1-propanol-2-amide is an EPA-containing MAG amide analog that inhibits the growth of human lung carcinoma A549 cells, producing 98.4% growth inhibition when applied at 3 µM.{27848} It is an analog of eicosapentaenoyl ethanolamide (Item No. 10964), a natural N-acylethanolamide that impacts aging and inflammation.{19623,19740}  

 

Available on backorder

SKU: - Category:

Description

An EPA-containing MAG amide analog that inhibits the growth of human lung carcinoma A549 cells, producing 98.4% growth inhibition when applied at 3 µM; an analog of EPEA, a natural N-acylethanolamide that impacts aging and inflammation


Formal name: N-​(2-​hydroxy-​1-​methylethyl)​-5Z,8Z,11Z,14Z,17Z-eicosapentaenamide

Synonyms: 

Molecular weight: 359.6

CAS: 1638355-66-4

Purity: ≥98%

Formulation: A solution in ethanol


Product Type|Biochemicals|Lipids|Fatty Amides||Research Area|Cancer||Research Area|Lipid Biochemistry|Endocannabinoid/Endocannabinoid-like||Research Area|Lipid Biochemistry|Glycerolipids